Technology
-

There is a clinical trial running right now in which GLP-1 drugs, the same molecules behind Ozempic and Wegovy, are being tested for their effect on emotional blunting. Separately, consumer neurostimulation headsets are being marketed to flatten anxiety on demand. A startup in San Francisco is offering a subscription that adjusts your baseline mood the…
-

We inherit a great deal from the people who came before us. Their land, their debts, their noses, their predispositions to certain diseases. What we do not inherit, frustratingly, is the one thing that might actually be useful: what they knew. Every generation arrives at the same problems with the same blank slate, rediscovering grief…

